Autopsy report · NCT04679389
Acetazolamide Efficacy in Ataxia in PMM2-CDG
Cause of deathFunding or business
“Lack of funding”
Life of this trial
- Registered 3 months before it started.
- Ran for about 2 years 10 months before it stopped.
- 25 participants enrolled.
- Results were posted on the registry 1 year 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2, Phase 3
- Sponsor
- Mayo Clinic
- Sponsor type
- University, hospital or other
- Conditions
- Pmm2-CDG; CDG1A
- Interventions
- Placebo; Acetazolamide
- Participants
- 25
- Sites
- 3
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.